1.5 mg semaglutide to tirzepatide Troubling Findings in Study of GLP-1 Compounders Switching between weight-loss medications -

Conclusion Semaglutide is primarily used for managing type 2 diabetes and supporting weight loss in individuals with obesity or overweight conditions

Research has shown that patients on Semaglutide who followed a structured diet were more likely to experience consistent weight loss and fewer side effects

However, using compounded products as a replacement can be risky

Studies show GIP receptor activation on fat tissue promotes improved lipid handling, enhanced insulin sensitivity in fat cells specifically, and changes in fat distribution patterns

And once youve done it once, everything starts to feel more natural

Phase 2: 0.5mg weekly (weeks 5 through 8) This is where things start to shift